contrast
highthroughput
screen
virtual
ligand
screen
vs
compound
select
use
comput
program
predict
bind
target
receptor
key
prerequisit
knowledg
spatial
energet
criteria
respons
proteinligand
bind
concept
prerequisit
perform
vs
summar
explan
sought
endur
limit
technolog
target
select
analysi
prepar
discuss
well
consider
compil
candid
ligand
librari
tool
strategi
vs
campaign
accuraci
score
rank
result
also
consid
late
earli
experiment
highthroughput
screen
ht
combinatori
chemistri
aggress
develop
overcom
lead
discoveri
bottleneck
drug
develop
use
sophist
largescal
autom
anticip
would
gener
unpreced
number
novel
lead
result
substanti
increas
novel
drug
entiti
launch
market
per
year
howev
realiti
opposit
case
frequent
discov
hit
could
valid
optim
actual
lead
preclin
candid
thu
initi
euphoria
surround
approach
subsid
owe
disappointingli
low
hit
rate
signific
cost
involv
situat
fuel
consider
develop
altern
techniqu
express
virtual
screen
vs
coin
late
howev
techniqu
involv
much
older
effort
show
search
lead
candid
use
comput
seriou
altern
ht
term
vs
adopt
commun
contrast
ht
larg
phenomenolog
technolog
driven
vs
compound
select
predict
bind
macromolecular
target
use
comput
program
drug
discoveri
term
target
receptor
use
frequent
describ
macromolecul
drug
bind
usual
protein
also
dna
rna
compound
studi
necessarili
exist
test
consum
valuabl
substanc
materi
experiment
defici
limit
solubl
aggreg
format
sort
influenc
could
possibl
interfer
experiment
appli
assay
condit
need
consid
initi
comput
screen
contrast
ht
vs
requir
key
prerequisit
knowledg
spatial
energet
criteria
respons
bind
particular
candid
ligand
receptor
investig
consequ
either
threedimension
structur
macromolecular
target
given
crystal
structur
analys
nmr
sophist
homolog
model
least
rigid
refer
ligand
known
bioactiv
conform
map
put
receptor
bind
site
must
avail
defin
vs
knowledgedriven
approach
even
though
like
multipl
screen
campaign
perform
parallel
industri
recent
mcmaster
univers
launch
open
unbias
competit
screen
escherichia
coli
dihydrofol
reductas
detect
inhibitor
assess
well
vs
enrich
candid
ligand
compar
ht
random
screen
origin
sampl
set
compound
use
screen
split
two
one
fraction
test
ht
obtain
hit
report
serv
train
set
valid
tailor
appli
vs
tool
differ
research
group
enter
competit
retriev
hit
also
detect
experiment
screen
second
portion
screen
sampl
subsequ
total
unbias
fashion
second
part
data
sampl
evalu
ht
vs
parallel
unexpectedli
second
portion
show
hit
competit
inhibitor
would
expect
ligand
dock
substrat
bind
site
target
protein
interestingli
brenk
et
al
report
promis
hit
found
dock
detect
inhibitor
initi
ht
retest
higher
concentr
indic
weak
inhibit
observ
could
seen
support
view
vs
ht
complementari
approach
might
find
candid
miss
mention
method
involv
vs
much
older
approach
initi
attempt
find
ligand
dock
map
onto
ligandbas
pharmacophor
model
gener
prototyp
vs
approach
howev
term
use
time
probabl
comput
algorithm
fast
enough
enabl
larg
scale
applic
focus
approach
actual
make
use
avail
protein
structur
one
first
system
studi
dock
hiv
proteas
initi
version
program
dock
develop
mani
year
kuntz
group
tri
dock
rigid
entri
cambridg
crystallograph
databas
protein
receptor
focus
primarili
shape
complementar
later
consid
chemic
complementar
kuntz
group
retriev
neurolept
drug
haloperidol
potenti
lead
dock
screen
use
databas
known
drug
molecul
input
howev
compound
would
administ
high
dose
far
beyond
toxicolog
toler
concentr
effect
inhibitor
proteas
nevertheless
haloperidol
lead
gave
rise
new
idea
develop
deriv
possess
mm
inhibit
hiv
proteas
later
dupontmerck
databas
search
retriev
substitut
terphenyl
deriv
put
lead
inhibit
proteas
optim
via
sixand
sevenmemb
ring
result
class
cyclic
urea
abl
replac
crucial
structur
water
molecul
proteas
time
target
carboxi
group
two
catalyt
aspart
via
two
appropri
place
hydroxi
function
sinc
earli
vs
attempt
plethora
case
studi
perform
list
success
stori
steadili
grow
despit
fact
vs
still
young
disciplin
review
frequent
recent
comprehens
overview
kubinyi
one
exclud
pure
retrospect
studi
potenti
method
demonstr
abil
enrich
put
activ
molecul
sampl
anticip
nonact
one
target
studi
date
report
discoveri
mostli
micromolar
bind
ligand
truli
predict
fashion
avail
tabl
still
develop
far
matur
number
strategi
follow
vs
nearli
larg
number
report
screen
ing
campaign
owe
space
constraint
review
unabl
give
comprehens
overview
success
stori
investig
target
review
detail
current
appli
vs
protocol
accordingli
reader
recommend
consult
abovement
survey
instead
review
attempt
summar
comment
agre
concept
prerequisit
perform
success
vs
run
furthermor
attempt
analys
limit
approach
frank
plain
manner
seek
explain
limit
still
exist
accordingli
follow
section
first
target
select
analysi
prepar
discuss
follow
consider
compil
candid
ligand
screen
sampl
follow
discuss
actual
requir
tool
strategi
vs
campaign
final
remark
concern
accuraci
score
rank
screen
result
knowledgedriven
approach
scope
vs
strongli
depend
amount
qualiti
inform
avail
system
investig
clearli
avail
target
receptor
great
benefit
compar
situat
rigid
refer
ligand
known
target
receptor
could
macromolecular
biomolecul
either
protein
rna
dna
term
rigid
refer
ligand
either
substrat
inhibitor
molecul
agonist
antagonist
eg
steroid
hormon
could
serv
structur
target
receptor
becom
increasingli
avail
review
concentr
sole
situat
howev
mean
vs
appli
situat
structur
inform
target
receptor
avail
respect
dna
rna
target
receptor
develop
appropri
dock
score
tool
initi
recent
accordingli
vs
applic
target
still
rare
contrast
scope
applic
address
protein
rang
enzym
gproteincoupl
receptor
ion
channel
tabl
assess
druggabl
target
receptor
first
issu
consid
druggabl
select
target
select
protein
exhibit
bind
pocket
success
target
small
molecul
ligand
clearli
characterist
pocket
size
geometri
surfac
complex
rough
exposur
recognit
properti
complementar
shape
polar
respect
put
druglik
ligand
import
criteria
immedi
avail
pragmat
hardli
gener
applic
approach
would
correl
gene
famili
one
member
famili
abl
bind
drug
member
might
also
abl
bind
druglik
ligand
relat
physicochem
properti
assumpt
base
simpli
fact
member
gene
famili
usual
oper
relat
substrat
recogn
similar
endogen
ligand
howev
setup
vs
studi
requir
conclus
inform
actual
bindingsit
architectur
recent
hajduk
et
al
suggest
sever
decis
indic
help
discrimin
druggabl
nondrugg
bind
pocket
druggabl
total
surfac
area
portion
polar
contact
area
appear
benefici
along
appropri
pocket
compact
surfac
rough
complex
suggest
optim
size
composit
proteinbind
pocket
best
suit
recogn
accommod
small
organ
ligand
howev
analysi
hajduk
et
al
also
show
singl
index
consist
domin
correl
fact
point
complex
interrelationship
among
variou
discriminatori
indic
explain
present
concept
predict
druggabl
still
rudimentari
select
relev
geometri
target
receptor
select
appropri
geometri
target
anoth
import
issu
set
vs
run
power
method
learn
spatial
structur
protein
crystal
structur
analysi
accuraci
reliabl
method
strongli
depend
resolut
diffract
data
altern
experiment
techniqu
determin
protein
structur
nmr
accuraci
structur
determin
depend
strongli
local
distribut
nuclear
overhaus
effect
distanc
inform
along
protein
chain
effect
involv
transfer
magnet
space
give
inform
distanc
nuclei
structur
furthermor
past
signific
methodolog
enhanc
homolog
model
improv
qualiti
protein
model
accordingli
sever
success
vs
screen
campaign
report
base
modelbuilt
protein
structur
homolog
model
strongli
depend
avail
relat
protein
crystal
structur
determin
model
particularli
precis
area
homolog
experiment
determin
refer
high
usual
case
conserv
core
region
howev
function
bind
site
address
vs
gener
locat
loop
region
even
among
homologu
gene
famili
signific
differ
experienc
apart
catalyt
residu
enzym
spatial
highli
conserv
enhanc
accuraci
modelbuilt
structur
region
bind
site
found
new
algorithm
suggest
consid
put
bind
orient
known
ligand
homolog
model
process
algorithm
feed
inform
bind
properti
possibl
bound
ligand
back
homolog
build
process
improv
bind
site
geometri
expect
approach
anoth
obstacl
complic
vs
attempt
molecular
flexibl
ligand
protein
possess
intern
degre
freedom
adopt
variou
conform
state
respect
target
protein
sever
method
describ
simul
flexibl
vs
import
obtain
estim
protein
conform
compet
accommod
ligand
conform
determin
vs
run
either
perform
consid
flexibl
protein
instantli
calcul
address
ensembl
sever
rigid
receptor
conform
ligandbind
compet
conform
either
sampl
exhaust
conform
search
eg
use
molecular
dynam
simul
examin
multipl
conform
state
observ
crystal
structur
differ
ligand
bound
obtain
insight
relev
conform
latter
approach
appear
tempt
assum
sampl
experiment
observ
protein
conform
correspond
stabl
low
freeenergi
state
even
though
crystal
structur
usual
consid
gold
standard
learn
geometri
protein
highli
question
repres
singl
structur
determin
realli
mcgovern
shoichet
report
increas
inform
decay
irrespect
whether
geometri
ligandbound
ligandfre
crystal
structur
use
modelbuilt
structur
consid
princip
crystallin
proteinligand
complex
prepar
expos
preform
crystal
protein
solut
ligand
diffus
crystal
find
way
bind
site
process
call
soak
altern
cocrystal
experi
proteinligand
complex
form
equilibr
solut
assembl
complex
crystal
recent
observ
depend
soak
protocol
appli
differ
conform
state
protein
aldos
reductas
complex
inhibitor
zopolrestat
one
structur
protein
form
hydrogen
bond
ligand
via
one
bind
siteexpos
amid
bond
figur
second
structur
amid
bond
rotat
bind
site
ligand
longer
form
hydrogen
bond
differ
signific
impact
dock
score
result
vs
depend
crystal
condit
ligand
observ
accommod
bind
pocket
revers
orient
case
ligandinduc
conform
adapt
protein
observ
figur
increas
concentr
ligand
soak
buffer
enhanc
opportun
accommod
bind
pocket
howev
like
soak
depict
kind
kinet
trap
ligand
consequ
surpris
differ
cocrystal
observ
sever
ligand
bound
one
time
multipl
bind
mode
select
particular
crystal
structur
refer
vs
run
detail
analysi
paramet
popul
bound
ligand
bfactor
next
bind
site
bfactor
indic
thermal
motion
crystal
structur
howev
highli
correl
popul
ligand
crystal
consist
hydrogen
bond
network
advis
addit
program
use
actual
comput
screen
requir
properli
defin
proton
state
activesit
residu
mean
easi
perform
local
dielectr
drug
discoveri
today
volum
number
juli
review
inducedfit
adapt
two
differ
crystal
form
two
crystal
structur
benzamidin
case
accommod
deepli
buri
pocket
indic
deep
depress
leftand
righthand
imag
bound
trypsin
mutant
exhibit
bind
pocket
relat
factor
xa
crystal
structur
differ
term
conform
state
leftand
righthand
imag
left
rim
bind
pocket
red
surfac
expos
one
structur
orang
left
buri
green
right
adapt
involv
partial
unwind
short
threeturn
helix
centr
helix
lefthand
side
bind
pocket
rearrang
disulfid
bond
centr
yellow
bond
back
bind
mode
differ
soak
cocrystal
condit
crystal
structur
aldos
reductas
inhibitor
zopolrestat
shown
crystal
structur
determin
one
day
soak
yellow
differ
structur
obtain
six
day
soak
magenta
ident
obtain
cocrystal
light
blue
wherea
one
daysoak
structur
yellow
amid
bond
orient
nh
group
toward
inhibitor
form
hydrogen
bond
dot
yellow
line
bound
ligand
latter
two
structur
magenta
light
blue
amid
bond
rotat
away
inhibitor
hydrogen
bond
observ
wwwdrugdiscoverytodaycom
condit
modul
pk
valu
function
group
sever
order
magnitud
even
complex
present
difficult
calcul
pk
shift
residu
cours
ligand
bind
isotherm
titrat
calorimetri
measur
make
chang
appar
chang
probabl
occur
frequent
present
admit
easili
turn
acceptor
function
group
donor
chargeassist
hydrogen
bond
neutral
one
chang
signific
variou
valid
step
vs
run
recent
observ
even
proton
state
residu
bind
pocket
inhibitorbound
aldos
reductas
chang
depend
whether
cofactor
nadphnadp
present
oxid
reduc
state
figur
g
klebe
unpublish
result
respect
protein
flexibl
decis
taken
whether
vs
run
consid
one
singl
protein
conform
multipl
bindingcompet
state
receptor
differ
strategi
respect
dock
score
consequ
see
experi
show
conform
adapt
observ
proteinbind
pocket
usual
relat
structur
modul
potenti
need
protein
accomplish
function
role
function
adapt
must
correspond
lowenergi
transform
otherwis
dramat
shortcom
function
perform
protein
would
consequ
accordingli
enzym
oper
larg
palett
structur
divers
substrat
cf
aldos
reductas
short
chain
dehydrogenas
perform
substanti
conform
adapt
catalysi
cf
kinas
experi
multipl
bindingcompet
state
consid
vs
thu
profound
understand
function
properti
protein
might
best
option
predict
conform
adapt
protein
inform
usual
avail
begin
drug
develop
project
vs
use
protein
occur
gene
famili
close
relat
member
analysi
across
differ
entri
famili
might
provid
insight
flexibl
properti
inher
share
member
famili
howev
might
also
famili
member
display
rigid
solut
requir
function
eg
trypsin
factor
xa
among
serin
proteas
wherea
other
possess
pronounc
flexibl
behaviour
appropri
function
eg
serin
proteas
factor
viia
proton
state
chang
upon
ligand
bind
depend
oxid
state
bound
cofactor
nadph
left
nadp
right
aldos
reductas
bind
carboxylatetyp
inhibitor
eg
place
acid
function
group
red
catalyt
centr
complex
therebi
form
remain
either
unchang
proton
state
left
pick
proton
upon
bind
right
centr
crystal
structur
complex
shown
short
contact
distanc
carboxyl
function
inhibitor
shown
yellow
surfac
nicotinamid
portion
cofactor
shown
atomtyp
colour
surfac
oxygen
red
nitrogen
blue
carbon
white
sulfur
yellow
phosphor
orang
form
high
resolut
xray
crystal
structur
analysi
neutron
diffract
provid
evid
inhibitor
bind
carboxyl
function
deproton
state
activ
site
present
neutral
state
remain
unresolv
proton
goe
case
nadp
bound
complex
whether
residu
catalyt
centr
exhibit
deviat
proton
state
uncomplex
inhibit
situat
respect
vs
uniqu
precis
assign
proton
state
ligand
protein
function
group
pk
rang
essenti
exampl
dock
import
whether
group
consid
donor
acceptor
hydrogen
bond
klebe
unpublish
reliabl
relev
protein
conform
select
target
protein
assess
bindingsit
properti
map
blindli
start
vs
run
see
strategi
help
user
evalu
properti
target
protein
better
subsequ
examin
relev
dock
solut
suggest
vs
sever
tool
describ
elucid
hot
spot
bind
particular
bind
pocket
method
either
base
thoroughli
parameter
forc
field
wellselect
empir
inform
superstar
drugscor
figur
importantli
analysi
perform
multipl
conform
state
bind
pocket
provid
composit
pictur
molecular
recognit
properti
bind
site
might
chang
upon
protein
adapt
water
nasti
third
bind
partner
proteinligand
complex
final
crucial
decis
respect
setup
protein
refer
vs
run
concern
consider
water
molecul
bind
site
analysi
sever
thousand
crystal
structur
ligandprotein
complex
use
waterbas
modul
relibas
reveal
twothird
case
water
molecul
involv
ligand
bind
frequent
mediat
contact
protein
ligand
thu
approach
base
predict
bind
mode
put
candid
ligand
requir
vs
must
take
water
consider
one
possibl
approach
learn
water
molecul
tightli
bound
protein
analysi
crystallograph
data
respect
repeat
occurr
water
molecul
structur
relat
bind
site
eg
gene
famili
multipl
structur
determin
protein
mani
distinct
ligand
water
present
structur
analys
less
locat
strong
indic
water
molecul
tightli
bound
vs
run
could
consid
integr
part
target
structur
ht
vs
need
thought
design
thoroughli
compil
sampl
small
molecul
candid
ligand
screen
pharmaceut
compani
primarili
screen
proprietari
compound
collect
advantag
detect
hit
exclus
cover
molecul
synthesi
wellestablish
site
howev
sampl
pool
bias
well
avail
chemic
space
cover
consider
led
larg
pharma
compani
complement
inhous
collect
compound
offer
commerci
supplier
start
avail
chemic
directori
initi
prototyp
see
mdl
http
wwwmdlicom
current
million
uniqu
purchas
compound
offer
well
cover
chemic
space
portion
space
repres
druglik
molecul
dramat
figur
propos
concern
number
organ
molecul
consid
druglik
usual
molecul
meet
criteria
compos
element
h
c
n
p
cl
br
possess
molecular
weight
da
divers
entri
compound
databas
use
screen
physicochem
properti
met
candid
guarante
suffici
bioavail
concept
wellbalanc
homogen
popul
space
divers
druglik
molecul
appear
tempt
howev
proper
definit
descriptor
use
coordin
axe
compound
space
divers
context
criterion
similar
express
divers
rel
measur
relat
refer
point
vs
refer
point
target
receptor
differ
bind
map
hot
spot
bind
hotspot
analysi
use
drugscor
bind
pocket
trna
guanin
transglycosylas
surfac
bind
pocket
indic
white
region
energet
favour
bind
hydrogen
bond
donor
group
repres
nh
group
acceptor
group
repres
co
group
hydrophob
molecular
portion
repres
aromat
carbon
atom
car
analys
contour
three
subsequ
level
indic
use
three
differ
colour
deepest
energi
minimum
found
atom
type
map
crystallograph
determin
bind
mode
inhibitor
shown
superimpos
wwwdrugdiscoverytodaycom
affin
two
ligand
respect
structur
defin
whether
two
molecul
classifi
similar
divers
imagin
one
target
correctli
place
methyl
group
ligand
might
dramat
effect
bind
affin
wherea
anoth
toler
chang
bind
affin
first
case
ligand
without
methyl
group
would
term
divers
wherea
second
call
similar
howev
consult
divers
score
concentr
sole
topolog
ligand
methyl
unsubstitut
deriv
probabl
rank
highli
similar
optim
size
candid
ligand
submit
screen
past
combinatori
chemistri
particular
enabl
pharmaceut
compani
develop
screen
librari
sever
million
candid
molecul
thu
principl
sheer
number
test
compound
longer
issu
although
larg
total
count
individu
member
librari
usual
larg
term
size
molecular
weight
mostli
rang
typic
drugsiz
molecul
synthes
drug
develop
project
howev
turn
micromolar
screen
hit
still
requir
optim
improv
affin
toward
target
protein
two
three
order
magnitud
accomplish
maintain
reason
molecular
size
appropri
absorpt
distribut
metabol
excret
properti
consequ
involv
strip
scarc
decor
core
skeleton
subsequ
build
core
novel
welltailor
side
chain
challeng
task
often
difficult
achiev
experi
drug
optim
program
shown
small
core
fragment
privileg
templat
fragment
known
bind
signific
affin
ideal
start
point
optim
accordingli
compound
select
vs
leav
room
optim
thu
match
rang
socal
leadlik
fragmentlik
molecul
verdonk
et
al
present
insight
discuss
approach
taken
construct
databas
vs
suggest
method
involv
valid
eg
assess
enrich
rate
known
binder
purpos
vs
campaign
known
binder
pool
sampl
set
screen
candid
assess
well
known
binder
enrich
cours
screen
process
consider
import
develop
new
method
howev
actual
drug
develop
project
end
day
medicin
chemist
ask
novel
lead
worthwhil
pursu
synthesi
optim
impress
enrich
rate
known
activ
convinc
light
consider
suitabl
compound
collect
gener
criteria
match
either
inhous
proprietari
compound
substanc
offer
commerci
supplier
compound
valid
respect
drug
like
consid
lipinski
rule
five
lead
like
appli
stringent
criteria
defin
rule
three
recent
martin
test
lipinski
frequent
appli
rule
respect
experiment
determin
bioavail
rat
studi
show
rule
five
predict
abil
neutral
posit
charg
molecul
howev
anion
obey
differ
rule
size
polar
surfac
area
confer
predict
power
similarli
consider
concern
druggabl
bind
site
criteria
bioavail
multifactori
irwin
shoichet
took
initi
set
freeli
avail
databas
zinc
valid
compound
vs
built
compound
inform
gener
coordin
curat
possibl
stereoand
regioisomer
ambigu
multipl
state
respect
proton
charg
tautom
enumer
howev
describ
protein
properti
compound
might
alter
upon
protein
bind
insolubl
reactiv
aggreg
compound
repres
databas
rule
five
straightforward
filter
discard
compound
put
undesir
properti
screen
sampl
depend
strategi
pursu
subsequ
vs
campaign
multipl
conform
precalcul
store
separ
entri
databas
limit
search
sampl
purchas
compound
vs
pragmat
approach
screen
hypothes
test
rapidli
howev
vs
also
scan
virtual
compound
librari
synthesi
postpon
later
stage
consid
promis
hit
reymond
group
attempt
gener
databas
possibl
organ
molecul
da
constraint
defin
chemic
stabil
synthet
feasibl
databas
contain
million
entri
possibl
sampl
could
use
fragment
screen
larger
compound
exhaust
sampl
possibl
molecular
skeleton
end
combinatori
explos
mani
possibl
solut
howev
proper
design
criteria
defin
architectur
bind
site
use
vs
target
might
guid
gener
targettailor
virtual
librari
vs
particular
consid
criteria
combinatori
chemistri
parallel
synthesi
vs
strategi
actual
help
synthes
promis
entri
larg
virtual
combinatori
librari
princip
two
strategi
follow
vs
campaign
forward
backward
filter
hit
obtain
dock
crucial
step
vs
dock
candid
molecul
target
protein
forward
filter
variou
criteria
use
reduc
initi
data
sampl
might
compris
sever
million
test
compound
sever
hundr
thousand
promis
candid
dock
backward
filter
entri
data
sampl
dock
target
protein
filter
criteria
subsequ
appli
rank
gener
dock
solut
nowaday
speed
comput
longer
limit
factor
select
strategi
forward
techniqu
requir
fewer
comput
resourc
mainli
fact
hierarch
filter
drug
discoveri
today
volum
number
juli
step
signific
amount
origin
data
sampl
discard
howev
decreas
number
compound
filter
becom
comput
increasingli
demand
sophist
flexibl
dock
comput
intens
step
thu
fewer
candid
consid
effort
spent
control
valid
assess
dock
result
clearli
advantag
strategi
forward
filter
elimin
compound
initi
accord
simpl
descriptor
molecular
weight
number
rotat
bond
lipophil
usual
express
logarithm
partit
coeffici
log
p
crude
shape
descriptor
ellipt
overal
structur
subsequ
inform
receptor
bind
site
exploit
hotspot
analysi
like
anchor
posit
bind
pocket
perform
proteinbas
pharmacophor
deriv
pharmacophor
set
constraint
minim
requir
function
group
match
put
ligand
eg
number
hydrogen
bond
donor
acceptor
hydrophob
group
molecul
satisfi
criteria
retriev
databas
engin
capabl
function
group
substructur
search
topograph
arrang
proteinbas
pharmacophor
incorpor
search
remain
candid
request
match
pattern
studi
focus
uniti
uniti
chemic
inform
softwar
version
tripo
catalyst
prototyp
databas
engin
support
screen
step
altern
tool
featuretre
retriev
molecul
similar
topolog
featur
space
context
featur
consid
similar
type
function
group
molecular
build
block
similar
consid
filter
criterion
vs
exampl
candid
molecul
request
match
predefin
proteinbas
pharmacophor
condit
alreadi
involv
select
term
similar
criteria
howev
regard
gener
furthermor
inform
known
binder
use
filter
although
danger
exist
owe
bias
filter
preconceiv
concept
unexpect
novel
chemistri
discard
earli
filter
step
final
dock
pursu
usual
consid
initi
sampl
collect
advantag
forward
filter
approach
enabl
elabor
dock
protocol
perform
exampl
take
multipl
protein
conform
state
account
reflect
proteinbas
pharmacophor
restraint
dock
importantli
hierarch
filter
strategi
enabl
track
perform
variou
filter
level
human
intervent
particular
visual
inspect
dock
solut
remain
feasibl
backward
filter
start
highthroughput
dock
analys
gener
dock
mode
subsequ
step
approach
especi
challeng
dock
return
multipl
solut
candid
molecul
strongli
discrimin
reliabl
score
function
must
avail
analys
comput
result
autom
fashion
visual
inspect
larg
number
divers
compound
examin
hardli
feasibl
howev
question
whether
exist
score
function
reliabl
enough
succeed
heroic
demand
see
nevertheless
proceed
multipl
dock
solut
highthroughput
run
gener
dock
mode
filter
respect
achiev
match
proteinbas
pharmacophor
contact
complementar
protein
ligand
surfac
remain
residu
unoccupi
void
along
proteinligand
interfac
natur
probabl
avoid
gap
molecular
assembl
latter
criterion
could
power
indic
irrelev
bind
mode
put
accommod
interstiti
water
molecul
dock
crucial
step
vs
semin
program
dock
origin
describ
kuntz
et
al
evolv
first
vs
tool
later
program
success
appli
vs
gold
flexx
glide
autodock
name
popular
prototyp
recent
review
dock
tool
follow
slightli
differ
concept
might
give
individu
program
particular
advantag
one
task
respect
anoth
exampl
incorpor
aspect
flexibl
ligand
receptor
restrain
dock
search
engin
particular
region
configur
space
eg
map
proteinbas
pharmacophor
howev
dock
tool
still
far
perfect
even
challeng
carelessli
disregard
aspect
dock
appropri
consider
water
molecul
indic
water
molecul
involv
bind
twothird
known
proteinligand
complex
howev
dock
tool
ignor
simpli
conclus
concept
consid
correctli
miss
structur
evid
given
preplac
water
molecul
dock
run
feasibl
strategi
dock
tool
slide
treat
preplac
water
molecul
way
still
enabl
replac
ligand
atom
dock
particl
concept
flexx
enabl
placement
water
molecul
fli
cours
gener
individu
dock
solut
dock
tool
gold
water
molecul
switch
spin
around
princip
axe
achiev
good
contact
dock
ligand
recent
popular
dock
tool
dock
flexx
equip
featur
enabl
dock
preconceiv
pharmacophor
properti
distribut
consider
criteria
drive
dock
solut
especi
region
either
frequent
trap
bound
ligand
featur
complementari
analyt
tool
particularli
relev
bind
program
autodock
perform
dock
precalcul
grid
store
potenti
valu
sort
interact
field
origin
implement
lennardjon
coulomb
potenti
valu
use
sotriff
et
al
replac
knowledgebas
potenti
origin
implement
drugscor
latter
potenti
proven
power
discrimin
rank
among
multipl
ligand
pose
potenti
grid
approach
autodock
also
enabl
one
averag
across
field
produc
variou
protein
frame
conform
degre
freedom
protein
consid
addit
adapt
field
optim
respect
bind
properti
known
activ
compar
molecular
fieldtyp
approach
adapt
field
molecular
comparison
afmoc
use
target
potenti
valu
autodock
latter
dock
tool
perform
multipl
stochast
search
potenti
hypersurfac
accordingli
frequenc
occurr
certain
dock
solut
use
addit
figur
merit
relev
issu
optim
ligand
size
screen
address
complex
dock
problem
increas
size
ligand
number
rotat
bond
thu
smaller
molecul
typic
rang
ligand
fragment
simpler
dock
perplexingli
present
experi
indic
opposit
case
fragment
easili
scatter
bind
site
dock
reliabl
success
dock
occur
bind
site
restrict
size
show
dimens
similar
fragment
interestingli
experiment
approach
show
opposit
small
molecular
fragment
da
usual
popul
welldefin
manner
limit
number
site
bind
pocket
enrich
rate
control
achiev
virtual
screen
vs
run
usual
monitor
valid
compar
perform
set
known
activ
larg
number
randomli
pick
compound
activ
pool
random
entri
compound
submit
select
vs
protocol
perform
rank
known
activ
respect
remain
pool
convert
enrich
plot
process
essenti
keep
control
perform
achiev
vs
howev
choic
random
compound
librari
crucial
strongli
affect
enrich
obtain
accordingli
examin
whether
pool
randomli
pick
decoy
structur
actual
nonbind
reallif
scenario
note
merg
known
activ
set
candid
ligand
result
gradual
declin
enrich
rate
subsequ
hierarch
filter
step
novel
activ
retriev
vs
popul
promin
rank
dilut
set
predefin
known
activ
independ
actual
vs
strategi
appli
dock
subsequ
score
suggest
solut
key
performancedetermin
factor
vs
discriminatori
power
appli
score
function
utmost
import
rank
hope
enrich
potenti
activ
binder
top
list
dock
solut
consequ
myriad
score
function
develop
past
year
approach
taken
simpli
reli
one
singl
function
take
board
consensu
pictur
sever
score
scheme
character
bind
affin
put
lead
candid
experiment
bind
constant
invers
dissoci
constant
determin
approxim
valu
ic
assum
basic
rule
equilibrium
thermodynam
appli
defin
accord
law
mass
equilibrium
constant
describ
format
proteinligand
complex
equilibrium
constant
logarithm
relat
gibb
free
energi
compris
enthalp
entrop
contribut
wherea
former
relat
energet
featur
latter
concern
configur
order
phenomena
entrop
contribut
estim
energi
content
system
distribut
intern
extern
molecular
degre
freedom
three
strategi
follow
predict
bind
affin
basi
given
proteinligand
bind
geometri
rigor
theoret
solid
approach
firstprincipl
method
use
quantum
mechan
comput
less
demand
howev
approxim
forc
field
partit
function
system
comput
free
energi
differ
bound
unbound
state
determin
increas
speed
comput
method
becom
accur
obtain
grow
relev
score
howev
screen
larg
sampl
dock
solut
estim
bind
affin
still
far
beyond
tractabl
nevertheless
firstprincipl
method
need
calibr
train
experiment
determin
affin
data
thu
suffer
inher
experiment
shortcom
accuraci
limit
differ
two
approach
describ
follow
section
regressionand
knowledgebas
score
function
base
empir
concept
regressionbas
approach
assum
addit
individu
term
consid
master
equat
describ
total
gibb
free
energi
bind
context
term
reflect
physicochem
properti
relev
proteinligand
bind
process
exampl
number
charg
uncharg
hydrogen
bond
size
polar
nonpolar
surfac
portion
number
rotat
bond
enthalpi
requir
desolv
either
ligand
protein
among
other
assum
independ
individu
contribut
reproduc
known
affin
train
set
ligand
extract
regress
analysi
partial
leastsquar
analysi
neural
network
howev
independ
term
unlik
fair
strong
correl
term
probabl
correl
analysi
fact
might
point
anoth
first
glanc
surpris
properti
pop
best
explan
howev
might
case
latter
properti
essenti
physic
sens
highli
correl
anoth
properti
actual
crucial
recent
parameter
new
regressionbas
score
function
basi
larg
sampl
crystal
structur
known
affin
bound
ligand
depend
composit
train
set
differ
term
found
relev
analysi
clearli
show
empir
score
function
reflect
best
fit
respect
train
set
use
rare
achiev
gener
altern
regressionbas
approach
knowledgebas
score
function
evalu
occurr
fre
quenci
properti
interest
exampl
mutual
distanc
particular
atom
type
found
across
proteinligand
interfac
sampl
distribut
describ
occurr
probabl
compar
statist
mean
refer
situat
deviat
averag
translat
use
type
mathemat
relationship
statist
prefer
use
determin
geometri
proteinligand
complex
concept
knowledgebas
function
appear
gener
master
equat
preconceiv
term
requir
howev
data
select
deriv
function
definit
atom
type
togeth
mani
adjust
paramet
need
actual
establish
method
also
attenu
gener
approach
estim
bind
constant
regressionand
knowledgebas
score
function
requir
experiment
affin
data
intern
calibr
thu
predict
accuraci
never
better
precis
bind
data
measur
interest
note
estim
standard
deviat
empir
score
function
reduc
data
select
number
target
determin
one
laboratori
base
assay
data
record
strictli
conserv
condit
use
broadrang
data
cover
mani
target
consid
base
assay
data
determin
variou
laboratori
rel
differ
bind
data
within
seri
compound
determin
precis
usual
much
better
across
data
variou
system
comparison
perform
absolut
scale
consequ
standard
deviat
predict
bind
affin
present
avail
function
rang
logarithm
unit
bind
affin
rang
match
experiment
accuraci
achiev
bind
data
across
train
set
grow
heterogen
cover
broad
spectrum
target
experi
knowledgebas
score
function
better
abl
extract
bind
geometri
gener
dock
program
close
approxim
experiment
confirm
bind
mode
sampl
set
decoy
placement
contrast
regressionbas
score
function
better
actual
affin
predict
provid
fairli
accur
bind
geometri
given
unlik
profess
opinion
dock
geometri
problem
resolv
suffici
extent
score
problem
remain
open
question
appear
intim
relat
recent
develop
knowledgebas
score
function
base
accur
contact
data
small
molecul
crystal
data
function
reliabl
recogn
experiment
determin
bind
mode
found
crystal
structur
among
set
decoy
pose
appear
selfevid
score
problem
allevi
relev
nearn
bind
pose
produc
dock
program
reliabl
recogn
score
function
accordingli
appear
advis
drive
dock
solut
close
possibl
nativ
geometri
would
show
correspond
crystal
structur
also
achiev
optim
toward
nearn
situat
best
involv
minim
respect
function
use
score
disadvantag
process
would
comput
demand
bind
affin
suffici
well
understood
properti
discuss
score
rank
must
ask
question
well
understand
target
valu
gibb
free
energi
advis
focu
score
free
energi
would
better
treat
enthalpi
entropi
separ
term
score
mutual
compens
enthalpi
entropi
owe
fact
entiti
scatter
much
larger
rang
free
energi
consid
bind
ligand
protein
enthalpi
dh
entropi
td
easili
scatter
larger
rang
spread
gibb
free
energi
dg
mutual
compens
enthalpi
entropi
even
found
across
close
relat
molecul
figur
furthermor
mani
physicochem
phenomena
relev
bind
process
yet
fulli
understood
therefor
yet
correctli
incorpor
score
function
eg
role
water
chang
proton
state
appropri
consider
entropi
interestingli
microcalorimetri
indic
increas
temperatur
proteinligand
bind
process
becom
exotherm
entrop
less
favour
observ
appli
target
suggest
gener
phenomena
involv
yet
understood
molecular
level
despit
present
defici
understand
physic
bind
process
score
still
work
satisfactorili
like
consid
bind
ligand
protein
rel
scale
accordingli
unappreci
phenomena
similar
across
complex
analysi
simpli
cancel
exampl
mention
one
approach
reflect
protein
flexibl
appli
parallel
dock
sever
rigid
bindingcompet
conform
protein
disadvantag
strategi
fact
addit
degre
score
creat
discrimin
score
differ
protein
conform
cancel
unreflect
intern
protein
energi
contribut
longer
certain
studi
shown
special
score
scheme
protocol
requir
dramat
energi
differ
lowenergi
conform
unlik
modul
pocket
size
differ
protein
conform
might
requir
individu
score
alter
desolv
properti
bind
site
requir
accuraci
score
enrich
hit
identif
vs
use
enrich
put
activ
larg
sampl
set
test
ligand
accordingli
desir
accuraci
score
depend
whether
first
glanc
priorit
sampl
set
test
anticip
whether
put
activ
expect
among
top
ten
hit
list
latter
requir
power
discrimin
activ
inact
decoy
binder
present
score
function
optim
discrimin
particular
ligand
decoy
bind
mode
nearn
one
discrimin
binder
decoy
nonbind
still
remain
major
challeng
vs
protocol
worst
case
abovement
poorli
understood
contribut
bind
becom
overwhelmingli
import
perhap
consider
similar
criteria
search
enabl
problem
allevi
degre
drive
search
toward
close
relat
ligand
disregard
effect
score
cancel
ultim
proof
concept
crystal
structur
analysi
vs
hit
rare
crystal
structur
detect
vs
hit
determin
subsequ
publish
case
studi
recent
review
shoichet
case
describ
vs
correctli
predict
subsequ
found
bind
mode
exampl
point
defici
aris
superfici
understood
phenomena
describ
final
also
report
vs
inappropri
identifi
activ
compound
bind
actual
occur
total
differ
region
protein
surfac
vs
establish
power
altern
complement
ht
perform
optim
impress
hit
rate
report
significantli
higher
factor
ht
compar
studi
ht
vs
indic
method
captur
altern
complementari
ligand
undoubtedli
vs
yet
fulli
matur
technolog
follow
wellestablish
process
line
foundat
proteinligand
recognit
understood
well
enough
deploy
larg
scale
multicompound
effort
commonli
undertaken
vs
call
indepth
research
particular
protein
flexibl
inducedfit
adapt
role
water
solvat
desolv
ligand
bind
electrostat
involv
includ
chang
proton
state
appropri
consider
entrop
chang
need
better
understood
improv
hit
retriev
rate
vs
frequent
experiment
work
perform
parallel
followup
vs
campaign
provid
whole
bunch
unexpect
result
point
toward
manifold
defici
concept
appli
mani
experiment
studi
requir
nevertheless
vs
proven
success
valuabl
altern
ht
particular
use
tool
support
complement
hit
discoveri
compar
ht
significantli
cheaper
faster
use
easili
rerun
modifi
condit
exampl
addit
inform
target
protein
consider
becom
avail
novel
filter
criteria
taken
account
interest
note
experienc
model
medicin
chemist
often
figur
whether
particular
bind
pocket
appear
druggabl
certain
molecul
obey
rule
drug
like
howev
put
knowledg
comput
algorithm
make
multifactori
natur
rule
appar
complic
attempt
gener
multifactori
natur
hold
true
dock
score
therefor
highli
advis
refrain
fulli
autom
strategi
vs
experi
human
intervent
utmost
import
keep
control
variou
filter
step
vs
run
use
way
vs
success
particular
inform
molecular
similar
consid
term
gener
physicochem
properti
simpli
chemic
formula
con
drug
discoveri
today
volum
number
juli
similar
ligand
decompos
differ
enthalp
entrop
bind
contribut
crystal
structur
two
close
relat
thrombin
inhibitor
bear
cyclopentyl
cyclohexyl
moieti
termin
substitu
accommod
pocket
catalyt
site
surfac
bind
pocket
indic
blue
wherea
fivememb
ring
left
give
rise
welldefin
differ
electron
densiti
white
chickenwir
contour
sixmemb
ring
right
assign
densiti
see
insid
white
circl
like
latter
fragment
show
enhanc
residu
mobil
scatter
around
sever
conform
state
interestingli
deviat
behaviour
well
reflect
thermodynam
properti
centr
compound
exhibit
free
energi
bind
dg
blue
column
howev
cyclohexyl
deriv
right
enhanc
residu
mobil
entrop
td
red
column
favour
lesswel
clamp
fiver
deriv
left
latter
experi
better
enthalp
contribut
dh
green
column
bind
sider
similar
concept
take
risk
highli
divers
molecul
remain
undetect
howev
probabl
make
search
simpler
mani
paramet
actual
matter
vs
properli
consid
simpli
cancel
rel
comparison
consid
mention
limit
take
molecular
similar
kind
workaround
evad
exist
shortcom
critic
review
might
rais
question
whether
restrain
condit
vs
realli
contribut
someth
novel
experienc
medicin
chemist
would
thought
success
exampl
convinc
appli
vs
trnamodifi
enzym
inhibitor
replac
either
guanin
precursor
modifi
base
queuin
substrat
enzym
recognit
pocket
figur
initi
vs
search
retriev
structur
admittedli
experienc
medicin
chemist
might
also
suggest
substratelik
howev
followup
vs
screen
sever
water
molecul
allow
replac
bind
site
suggest
cyclic
urea
structur
differ
orient
bind
pocket
synthet
lead
appear
tempt
present
serv
start
point
new
seri
compound
figur
unbias
approach
result
chemic
term
unexpect
lead
demonstr
vs
make
import
contribut
drug
discoveri
provid
unexpect
candid
nevertheless
still
long
way
go
becom
establish
tool
routin
lead
discoveri
interestingli
nowaday
aspect
contemporari
drug
discoveri
optim
toward
high
throughput
contrast
current
increas
knowledg
understand
proteinligand
recognit
principl
still
proceed
lowoutput
rate
drug
discoveri
today
volum
number
juli
review
unexpect
ligand
skeleton
virtual
screen
virtual
screen
vs
use
search
put
inhibitor
trna
guanin
transglycosylas
initi
hit
lower
left
box
follow
chemic
synthesi
show
structur
similar
natur
substrat
enzym
guanin
preq
preq
upper
box
search
base
proteinbas
pharmacophor
shown
left
contour
hydrogen
bond
acceptor
group
figur
experienc
medicin
chemist
could
possibl
come
similar
suggest
potenti
lead
howev
second
vs
campaign
focus
replac
two
water
molecul
lower
right
rim
bind
pocket
trna
guanin
transglycosylas
right
contour
hydrogen
bond
acceptor
group
screen
suggest
potenti
hit
cyclic
ureatyp
skeleton
distinct
structur
bind
mode
known
natur
substrat
serv
synthet
easili
access
lead
sever
deriv
eg
synthes
show
reason
structureact
relationship
stengl
et
al
unpublish
unlik
novel
lead
structur
would
suggest
compar
substrat
consider
exampl
underlin
power
vs
altern
sourc
novel
lead
discoveri
wwwdrugdiscoverytodaycom
review
foundat
review
